CoChat
Sign Up
Cited by 138Alzheimer's disease research and treatmentsIntracerebral and Subarachnoid Hemorrhage ResearchNeurological Disease Mechanisms and Treatments

The DOI matches its Crossref record; 64 of the 67 references it cites were found in a registry or an index.

Capillary cerebral amyloid angiopathy is associated with vessel occlusion and cerebral blood flow disturbances

Thal, Dietmar Rudolf, Capetillo-Zarate, Estibaliz, Larionov, Sergey, Staufenbiel, Matthias, Zurbruegg, Stefan, Beckmann, Nicolau·2009·Neurobiology of Aging
DOI 10.1016/j.neurobiolaging.2008.01.017
Open this paper in CoChat — free account

Abstract

The role of cerebral amyloid angiopathy (CAA) in the pathogenesis of Alzheimer's disease (AD) is not fully understood. Here, we studied whether CAA is associated with alterations in microvascularisation in transgenic mouse models and in the human brain. APP23 mice at 25-26 months of age exhibited severe CAA in thalamic vessels whereas APP51/16 mice did not. Wild-type littermates were free of CAA. We found CAA-related capillary occlusion within the thalamus of APP23 mice but not in APP51/16 and wild-type mice. Magnetic resonance angiography (MRA) showed blood flow alterations in the thalamic vessels of APP23 mice. CAA-related capillary occlusion in the branches of the thalamoperforating arteries of APP23 mice, thereby, corresponded to the occurrence of blood flow disturbances. Similarly, CAA-related capillary occlusion was observed in the human occipital cortex of AD cases but less frequently in controls. These results indicate that capillary CAA can result in capillary occlusion and is associated with cerebral blood flow disturbances providing an additional mechanism for toxic effects of the amyloid beta-protein in AD.

Overview

Integrity signals

Registry

Crossref · 10.1016/j.neurobiolaging.2008.01.017

Cites

64 of 64 references verified0 citation errors · 0 not checkable

Statistics

Recomputing p-values needs the paper’s full text.

Verification

Claims the paper makes

This paper’s full text isn’t openly available, so its claims and self-check weren’t run. The registry and citation checks still apply.

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

Citations

Cites

Flagged first, then by citations

Show all 67 references

3 of the 67 references couldn’t be matched to a known paper.

Research works printed but not linked: 2

  1. Kalimo, 1997, Vascular diseases, vol. 1, 315
  2. Kim, 1988, Production and characterization of monoclonal antibodies reactive to synthetic cerebrovascular amyloid peptide, Neurosci. Res. Commun., 2, 121

Cited by

Sorted by citations

Items 101–138 of 138

Related

See all

Metadata

Authors
Thal, D. R., Capetillo-Zarate, E., Larionov, S., Staufenbiel, M., Zurbruegg, S., & Beckmann, N.
Affiliations
  • University of Bonn (DE)
  • Novartis (Switzerland) (CH)
Corresponding author
Thal, Dietmar Rudolf
ORCID
Venue
Neurobiology of Aging
Publisher
Elsevier BV
Published
2009-12
Volume
30
Issue
12
Pages
1936-1948
ISSN
0197-4580 (ISSN-L)
DOI
10.1016/j.neurobiolaging.2008.01.017
OpenAlex
W1994609866
Cited by
138
References
67
Citations by year
2026: 3 · 2025: 5 · 2024: 5 · 2023: 3 · 2022: 13 · 2021: 14 · 2020: 5 · 2019: 6 · 2018: 6 · 2017: 6 · 2016: 9 · 2015: 7 · 2014: 8 · 2013: 9 · 2012: 10
FWCI
6.56
Type
journal article
Language
en
Open access
closed
Licence
www.elsevier.com/tdm/userlicense/1.0/ (tdm)
Locations
  • Neurobiology of Aging (publishedVersion)
  • PubMed (publishedVersion)
Funders
  • Chinese Academy of Agricultural Sciences
  • Novartis Institutes for BioMedical Research
Topics
  • Life Sciences › Neuroscience › Cellular and Molecular Neuroscience › Alzheimer's disease research and treatments
  • Health Sciences › Medicine › Clinical Neurology › Intracerebral and Subarachnoid Hemorrhage Research
  • Life Sciences › Neuroscience › Neurology › Neurological Disease Mechanisms and Treatments
Keywords
cerebral amyloid angiopathy, capillary occlusion, cerebral blood flow, Alzheimer's disease, APP23 mice, thalamus, amyloid-beta, microvascular dysfunction, occipital cortex, transgenic mouse model
MeSH terms
Adult, Aged, Aged, 80 and over, Alzheimer Disease, Animals, Brain, Capillaries, Cerebrovascular Circulation, Disease Models, Animal, Female, Humans, Male, Mice, Inbred C57BL, Mice, Transgenic, Middle Aged, Occipital Lobe, Species Specificity, Thalamus, Cerebral Amyloid Angiopathy, Mice, Microvessels

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review